In a recent analysis of 232 cervical adenocarcinoma samples, VEGF-A was reported to be coexpressed with metabolism-related proteins (monocarboxylate transporters (MCT)), in particular, with the MCT4 isoform, allowing the conclusion that the angiogenic switch and the metabolic remodeling synergistically act to affect cervical adenocarcinomas aggressiveness [251]. This evidence concerns the gene VEGFA and cervical adenocarcinoma.